Literature DB >> 27000760

Comment on: "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

Henrique Horta Veloso1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27000760     DOI： 10.1007/s40262-016-0380-9

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  7 in total

1.  Digoxin versus placebo for conversion of acute atrial fibrillation to sinus rhythm.

Authors:  H H Veloso; A A de Paola
Journal:  Am J Cardiol       Date:  1999-04-15       Impact factor: 2.778

2.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Valentin Fuster; Lars E Rydén; Davis S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Huezey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann; Sidney C Smith; Silvia G Priori; N A Mark Estes; Michael D Ezekowitz; Warren M Jackman; Craig T January; James E Lowe; Richard L Page; David J Slotwiner; William G Stevenson; Cynthia M Tracy; Alice K Jacobs; Jeffrey L Anderson; Nancy Albert; Christopher E Buller; Mark A Creager; Steven M Ettinger; Robert A Guyton; Jonathan L Halperin; Judith S Hochman; Frederick G Kushner; Erik Magnus Ohman; William G Stevenson; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

3.  The role of digitalis pharmacokinetics in converting atrial fibrillation and flutter to regular sinus rhythm.

Authors:  Roger W Jelliffe
Journal:  Clin Pharmacokinet       Date:  2014-05       Impact factor: 6.447

4.  Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.

Authors:  L Bianconi; M Mennuni
Journal:  Am J Cardiol       Date:  1998-09-01       Impact factor: 2.778

5.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

6.  Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

Authors:  L Jordaens; J Trouerbach; P Calle; R Tavernier; E Derycke; P Vertongen; B Bergez; Y Vandekerckhove
Journal:  Eur Heart J       Date:  1997-04       Impact factor: 29.983

7.  Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group.

Authors: 
Journal:  Eur Heart J       Date:  1997-04       Impact factor: 29.983
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.